You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

DANTRIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dantrium, and what generic alternatives are available?

Dantrium is a drug marketed by Endo Operations and is included in two NDAs.

The generic ingredient in DANTRIUM is dantrolene sodium. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dantrium

A generic version of DANTRIUM was approved as dantrolene sodium by IMPAX LABS on March 1st, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DANTRIUM?
  • What are the global sales for DANTRIUM?
  • What is Average Wholesale Price for DANTRIUM?
Drug patent expirations by year for DANTRIUM
Drug Prices for DANTRIUM

See drug prices for DANTRIUM

Recent Clinical Trials for DANTRIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beth Israel Deaconess Medical CenterPhase 2
University of Massachusetts, WorcesterPhase 1/Phase 2
American Heart AssociationPhase 1/Phase 2

See all DANTRIUM clinical trials

US Patents and Regulatory Information for DANTRIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium INJECTABLE;INJECTION 018264-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-003 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DANTRIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium INJECTABLE;INJECTION 018264-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Endo Operations DANTRIUM dantrolene sodium CAPSULE;ORAL 017443-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DANTRIUM

See the table below for patents covering DANTRIUM around the world.

Country Patent Number Title Estimated Expiration
Switzerland 483446 Verfahren zur Herstellung von 1-((5-substituierten)-Furfurylidenamino)-hydantoinen und -imidazolidinonen ⤷  Sign Up
Sweden 303758 ⤷  Sign Up
Denmark 116509 ⤷  Sign Up
Finland 45556 ⤷  Sign Up
Austria 263759 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.